(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...
Use of digital measurement tools to track individual adherence to treatment helped avoid raising doses or adding medications and improved adherence in patients with uncontrolled asthma, the INCA Sun ...
To claim CE credit for this activity, please visit https://www.pharmacytimes.org/courses/emerging-care-management-strategies-for-severe-asthma-integrating-biologic ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Mona Bafadhel receives funding from the National Institute of Health Research, Asthma+Lung UK, and Horizon Europe. For this study, Mona Bafadhel received funding from AstraZeneca to complete the study ...
asthma, lungs Authors review changes in the diagnosis, workup, and treatment of asthma in the 2022 GINA report. Some patients with asthma who lack evidence of type 2 inflammation are considered to ...
Speakers at the European Respiratory Society Congress 2024 provided updates to the 2 trials focusing on depemokimab for severe asthma and dupilumab for pediatric asthma. Late-breaking findings ...
Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...
Seven out of ten asthmatic patients report that cold air exacerbates their symptoms, according to research. As winter approaches, it is vital to plan for asthma control in advance. 1 Recommended by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results